The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

被引:113
作者
Liberati, Alessandro [1 ,2 ]
Altman, Douglas G. [3 ]
Tetzlaff, Jennifer [4 ]
Mulrow, Cynthia [5 ]
Gotzsche, Peter C. [6 ]
Ioannidis, John P. A. [7 ]
Clarke, Mike [8 ,9 ]
Devereaux, P. J. [10 ,11 ,12 ]
Kleijnen, Jos [13 ,14 ]
Moher, David [4 ,15 ]
机构
[1] Univ Modena & Reggio Emilia, Modena, Italy
[2] Ist Ric Farmacol Mario Negri, Ctr Cochrane Italiano, Milan, Italy
[3] Univ Oxford, Ctr Stat Med, Oxford, England
[4] Ottawa Hosp, Res Inst, Ottawa Methods Ctr, Ottawa, ON, Canada
[5] Annals Internal Med, Philadelphia, PA USA
[6] Nord Cochrane Ctr, Copenhagen, Denmark
[7] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece
[8] UK Cochrane Ctr, Oxford, England
[9] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland
[10] McMaster Univ, Dept Med, Hamilton, ON, Canada
[11] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada
[12] McMaster Univ, Dept Biostat, Hamilton, ON, Canada
[13] Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England
[14] Univ Maastricht, Sch Publ Hlth & Primary Care, CAPHRI, Maastricht, Netherlands
[15] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada
基金
加拿大健康研究院;
关键词
RANDOMIZED CONTROLLED-TRIALS; CORONARY-HEART-DISEASE; CRITICALLY-ILL PATIENTS; OUTCOME SELECTION BIAS; CLINICAL-TRIALS; PUBLICATION BIAS; PHARMACEUTICAL-INDUSTRY; DUPLICATE PUBLICATION; INFORMATIVE ABSTRACTS; STRUCTURED ABSTRACTS;
D O I
10.1371/journal.pmed.1000100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and transparency of these reports, however, is not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (QUality Of Reporting Of Meta-analysis) Statement-a reporting guideline published in 1999-there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realizing these issues, an international group that included experienced authors and methodologists developed PRISMA ( Preferred Reporting Items for Systematic reviews and Meta-Analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions. The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this Explanation and Elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA Statement, this document, and the associated Web site (http://www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and metaanalyses.
引用
收藏
页数:28
相关论文
共 221 条
[1]   Interventions to improve outpatient referrals from primary care to secondary care [J].
Akbari, Ayub ;
Mayhew, Alain ;
Al-Alawi, Manal Alawi ;
Grimshaw, Jeremy ;
Winkens, Ron ;
Glidewell, Elizabeth ;
Pritchard, Chanie ;
Thomas, Ruth ;
Fraser, Cynthia .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04)
[2]   Non-steroidal anti-inflammatory drugs for pain in women with endometriosis [J].
Allen, C. ;
Hopewell, S. ;
Prentice, A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04)
[3]   Association of funding and conclusions in randomized drug trials - A reflection of treatment effect or adverse events? [J].
Als-Nielsen, B ;
Chen, WD ;
Gluud, C ;
Kjaergard, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :921-928
[4]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[5]  
ALTMAN DG, 2001, BMJ RAPID RESPONSE
[6]   EQUATOR: reporting guidelines for health research [J].
Altman, Douglas G. ;
Simera, Iveta ;
Hoey, John ;
Moher, David ;
Schutz, Ken .
LANCET, 2008, 371 (9619) :1149-1150
[7]   Developing guidelines for reporting healthcare research: scientific rationale and procedures [J].
Altman, Douglas G. ;
Moher, David .
MEDICINA CLINICA, 2005, 125 :8-13
[8]   World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects [J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (20) :2191-2194
[9]  
[Anonymous], 2008, INTRO RIVER ICE BREA
[10]  
[Anonymous], 2009, Systematic reviews: CRD's guidancefor undertaking reviews in health care